Dramatic response of metastatic cutaneous angiosarcoma to an immune checkpoint inhibitor in a patient with xeroderma pigmentosum: whole-genome sequencing aids treatment decision in end-stage disease.

Thumbnail
View / Open Files
Authors
Momen, Sophie
Fassihi, Hiva
Davies, Helen
Nikolaou, Christos
  Degasperi, Andrea
Stefanato, Catherine M
  Dias, Joao ML
Publication Date
2019-10-23
Journal Title
Cold Spring Harbor molecular case studies
ISSN
2373-2873
Volume
5
Issue
5
Language
eng
Type
Article
This Version
VoR
Physical Medium
Electronic-Print
Metadata
Show full item record
Citation
Momen, S., Fassihi, H., Davies, H., Nikolaou, C., Degasperi, A., Stefanato, C. M., Dias, J. M., et al. (2019). Dramatic response of metastatic cutaneous angiosarcoma to an immune checkpoint inhibitor in a patient with xeroderma pigmentosum: whole-genome sequencing aids treatment decision in end-stage disease.. Cold Spring Harbor molecular case studies, 5 (5)https://doi.org/10.1101/mcs.a004408
Keywords
Humans, Hemangiosarcoma, Skin Neoplasms, Xeroderma Pigmentosum, DNA Polymerase II, Antibodies, Monoclonal, DNA Mutational Analysis, Mutation, Adult, Male, Microsatellite Instability, Antibodies, Monoclonal, Humanized, Programmed Cell Death 1 Receptor, Whole Genome Sequencing, Poly-ADP-Ribose Binding Proteins, B7-H1 Antigen
Sponsorship
Cancer Research UK (23916)
Identifiers
External DOI: https://doi.org/10.1101/mcs.a004408
This record's URL: https://www.repository.cam.ac.uk/handle/1810/298879

Rights
Attribution 4.0 International
Licence URL: https://creativecommons.org/licenses/by/4.0/

Attribution 4.0 International
Except where otherwise noted, this item's licence is described as Attribution 4.0 International